Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Non Operating Income: 2016-2025

Historic Non Operating Income for Anaptysbio (ANAB) over the last 10 years, with Sep 2025 value amounting to -$19.6 million.

  • Anaptysbio's Non Operating Income fell 94.09% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.9 million, marking a year-over-year decrease of 206.37%. This contributed to the annual value of -$30.3 million for FY2024, which is 3942.51% down from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Non Operating Income is -$19.6 million, which was down 57.72% from -$12.4 million recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Non Operating Income peaked at $424,000 during Q3 2023, and registered a low of -$19.6 million during Q3 2025.
  • Its 3-year average for Non Operating Income is -$6.7 million, with a median of -$6.3 million in 2024.
  • Per our database at Business Quant, Anaptysbio's Non Operating Income surged by 110.96% in 2023 and then slumped by 15,050.00% in 2024.
  • Anaptysbio's Non Operating Income (Quarterly) stood at -$1.4 million in 2021, then skyrocketed by 69.88% to -$416,000 in 2022, then skyrocketed by 80.77% to -$80,000 in 2023, then slumped by 15,050.00% to -$12.1 million in 2024, then crashed by 94.09% to -$19.6 million in 2025.
  • Its Non Operating Income was -$19.6 million in Q3 2025, compared to -$12.4 million in Q2 2025 and -$11.7 million in Q1 2025.